SCHEMBL4470282

SCHEMBL4470282

CC(C)(C)c1ccc(-c2nc3ccnc(Cl)c3[nH]2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.51
TNKS O95271 6/20 0.47
TNKS2 Q9H2K2 6/20 0.47
GCGR P47871 1/20 0.46
PARP1 P09874 4/20 0.43
TRPV1 Q8NER1 3/20 0.43
NPBWR1 P48145 1/20 0.42
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
AURKA O14965 1/20 0.40
SCD O00767 1/20 0.39
KIF11 P52732 2/20 0.38
HRH4 Q9H3N8 1/20 0.37
METAP2 P50579 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9693499 0.83 ALDH1A1 (0.58) TNKSTNKS2GCGRNPBWR1KDM4E
SCHEMBL28563694 0.80 KDM4E (0.47) TNKSTNKS2PARP1KDM4ENPC1
SCHEMBL22191835 0.75 NPC1 (0.53) TNKSTNKS2NPBWR1NPC1ALDH1A1
SCHEMBL4468341 0.75 PRKCI (0.47) HDAC6TNKSTNKS2GCGRPARP1
SCHEMBL13864512 0.74 ALDH1A1 (0.66) HDAC6TNKSTNKS2GCGRTRPV1
SCHEMBL4465876 0.74 HDAC6 (0.61) HDAC6TNKSTNKS2GCGRPARP1
SCHEMBL3286054 0.72 HDAC6 (0.60) HDAC6TNKSTNKS2GCGRPARP1
SCHEMBL4190003 0.71 TRPV1 (0.56) HDAC6GCGRTRPV1NPBWR1AURKA
SCHEMBL21705583 0.71 HDAC6 (0.66) HDAC6TNKSTNKS2GCGRPARP1
SCHEMBL31027907 0.71 HDAC6 (0.66) HDAC6TNKSTNKS2GCGRPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538113-B2 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-26 US disclosed
US-7538113-B2 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-26 US disclosed
US-7538113-B2 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-26 US disclosed
US-20060189618-A1 4-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189618-A1 4-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor GNRHR, LHCGR, FSHR HDAC6 1529/4885TNKS 2751/4885TNKS2 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.